Latest News
Visa Eyes Key Economic Data After Mixed Week, Launches Small-Business Initiative
Visa shares edged higher Friday, closing at $331.58, as traders await a deluge of delayed U.S. economic reports next week that could sway consumer spending and rate expectations.
JNJ Nears 52-Week Peak Amid Legal Win and Promising Heart Device Data
Johnson & Johnson shares approach a 52-week high after a New Jersey court disqualified a plaintiffs' firm from talc cases and the company released positive pilot data for its experimental atrial fibrillation platform.
Johnson & Johnson Stock Nears 52-Week High Amid Legal and Medical Device Updates
Johnson & Johnson shares approached a 52-week high as a New Jersey court disqualified a plaintiffs' firm from talc cases and the company reported positive pilot data for its atrial fibrillation platform.
ASML Rides Chip Rally Ahead of Key Economic Data and Dividend Date
ASML shares surged 4.6% on Friday, mirroring a 5.7% gain in the semiconductor index, as investors returned to AI-related stocks. Attention now turns to upcoming U.S. jobs data and the company's ex-dividend dates.
Samsung Eyes HBM4 Production Start for Nvidia Amid Market Scrutiny
Samsung Electronics is reportedly preparing to begin mass production of HBM4 memory chips for Nvidia later this month, with shipments expected after the Lunar New Year holiday.
Tencent's AI Cash Splash Meets WeChat Limits as Tech Sector Slips
Tencent shares fell 1.97% to HK$547.50 Friday amid a 1-billion-yuan AI giveaway and WeChat promotion restrictions, with the Hang Seng TECH Index dropping 1.11%.
Berkshire Hathaway's 13F Filing Looms as BRK.B Gains Amid Market Rotation
Berkshire Hathaway's Class B shares rose 0.83% to $508.09 as the Dow surpassed 50,000. Investors await the firm's delayed 13F holdings report due Feb. 17.
JPMorgan Surges 4% as Dow Breaks 50,000 Milestone; Focus Turns to Economic Data
JPMorgan Chase shares climbed nearly 4% on Friday, closing at $322.40, as the Dow Jones Industrial Average surpassed 50,000 for the first time. Investors now await key U.S. employment and inflation reports this week.
FDA Crackdown on Compounded Weight-Loss Drugs Boosts Eli Lilly Shares
Eli Lilly's stock rose 3.7% after the FDA warned Hims & Hers to halt sales of a non-approved compounded GLP-1 weight-loss pill, signaling a regulatory clampdown that may support pricing for branded obesity drugs.
